Question: Please describe this drug.
 The Compound has the SMILES OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O.
Result: Migalastat is pharmacologic chaperone of alpha-galactosidase the intrahepatic enzyme that is deficient in Fabry disease. Clinical experience with migalastat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O
(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol
Please describe this drug.
Migalastat is pharmacologic chaperone of alpha-galactosidase the intrahepatic enzyme that is deficient in Fabry disease. Clinical experience with migalastat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.